MEDICENNA THERAPEUTICS CORP (MDNA.CA) Stock Balance Sheet
TSX:MDNA - Toronto Stock Exchange - CA58490H1073 - Common Stock - Currency: CAD
| MRQ (2024-12-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 30.00M | 16.98M | 33.60M | 20.54M | 30.38M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 10.01M | |||
| Receivables | 1.43M | 1.16M | 860.00K | 1.31M | 410.00K | |||
| Other Current Assets | 588.00K | 931.00K | 1.93M | 1.55M | 1.35M | |||
| Total Current Assets | 32.01M | 19.08M | 36.39M | 23.39M | 42.15M | |||
| Non-Current Assets | ||||||||
| PPE Net | 175.00K | N/A | N/A | 0.00 | 30.00K | |||
| Intangibles | 53.00K | 57.00K | 60.00K | 70.00K | 70.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 228.00K | 57.00K | 60.00K | 70.00K | 100.00K | |||
| TOTAL ASSETS | 32.24M | 19.13M | 36.45M | 23.46M | 42.25M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 40.00K | N/A | N/A | 0.00 | 30.00K | |||
| Accrued Expenses | 1.25M | 793.00K | 2.18M | 950.00K | 1.83M | |||
| Accounts Payable | 1.88M | 2.07M | 1.62M | 1.67M | 2.25M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 3.17M | 2.86M | 3.80M | 2.62M | 4.11M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 134.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 11.48M | 11.08M | 3.16M | N/A | N/A | |||
| Total Non-Current Liabilities | 11.61M | 11.08M | 3.16M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 14.79M | 13.94M | 6.96M | 2.62M | 4.11M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -119.44M | -106.45M | -80.98M | -70.93M | -48.36M | |||
| Additional Paid In Capital | 20.55M | 10.70M | 9.49M | 7.93M | 6.68M | |||
| Common Shares | 116.30M | 100.92M | 100.92M | 83.67M | 79.59M | |||
| Other Shareholders' Equity | 42.00K | 19.00K | 60.00K | 170.00K | 230.00K | |||
| Shares Outstanding | 78.22M | 69.64M | 69.64M | 55.65M | 53.55M | |||
| Tangible Book Value per Share | 0.22 | 0.07 | 0.42 | 0.37 | 0.71 | |||
| Total Shareholders' Equity | 17.45M | 5.19M | 29.49M | 20.84M | 38.15M | |||
| TOTAL LIABILITIES AND EQUITY | 32.24M | 19.13M | 36.45M | 23.46M | 42.25M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 10.09 | 6.66 | 9.58 | 8.93 | 10.26 | |||
| Return On Assets (ROA) | -83.43% | -133.09% | -27.57% | -96.25% | -40.92% | |||
| Return On Equity (ROE) | -154.12% | -490.58% | -34.08% | -108.35% | -45.32% | |||
All data in CAD , ROIC based on taxRate of 0.28